KY SB27 | 2024 | Regular Session

Status

Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Engrossed on March 12 2024 - 50% progression, died in committee
Action: 2024-03-12 - to Health Services (H)
Pending: House Health Services Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

AN ACT relating to pharmaceutical manufacturers.

Sponsors


Roll Calls

2024-03-08 - Senate - Senate: Third Reading W/scs1 scta1 RSN# 2976 (Y: 32 N: 5 NV: 0 Abs: 1) [PASS]

History

DateChamberAction
2024-03-12Houseto Health Services (H)
2024-03-12Houseto Committee on Committees (H)
2024-03-12Housereceived in House
2024-03-08Senate3rd reading, passed 32-5 with Committee Substitute (1) and Committee Amendment (1-title)
2024-03-07Senateposted for passage in the Regular Orders of the Day for Friday, March 08, 2024
2024-02-22Senate2nd reading, to Rules
2024-02-21Senatereported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title)
2024-01-03Senateto Health Services (S)
2024-01-02Senateto Committee on Committees (S)
2024-01-02Senateintroduced in Senate

Subjects


Kentucky State Sources


Bill Comments

feedback